TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2017

Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology.

Amrita Y Krishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.